Masseter muscle myofibrillar protein synthesis and degradation in an experimental critical illness myopathy model

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Akkad, Hazem ^a   Corpeno, Rebeca ^a   Larsson, Lars ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; GELATINASE A; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MESSENGER RNA; MUSCLE PROTEIN; MUSCLE RING FINGER 1 PROTEIN; PROTEIN KINASE B;

ACTIN MYOSIN INTERACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; AUTOPHAGY; CONTROLLED STUDY; CRITICAL ILLNESS; ENZYME INHIBITION; FEMALE; GEL ELECTROPHORESIS; IMMOBILIZATION; IMMUNOBLOTTING; INTENSIVE CARE UNIT; MASSETER MUSCLE; MYOPATHY; NEUROMUSCULAR BLOCKING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; DISEASE MODEL; INTENSIVE CARE; METABOLISM; MUSCLE DISEASE; MUSCLE WEAKNESS; PATHOLOGY; SPRAGUE DAWLEY RAT; WASTING SYNDROME;

ANIMALS; CRITICAL ILLNESS; DISEASE MODELS, ANIMAL; FEMALE; INTENSIVE CARE; MASSETER MUSCLE; MUSCLE WEAKNESS; MUSCULAR DISEASES; PROTEIN BIOSYNTHESIS; PROTEOLYSIS; RATS; RATS, SPRAGUE-DAWLEY; WASTING SYNDROME;

EID: 84899418503     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092622     Document Type: Article

References (66)

1. Larsson L (2008) Acute quadriplegic myopathy: an acquired "myosinopathy". Adv Exp Med Biol 642: 92-98.
2. Latronico N, Tomelleri G, Filosto M (2012) Critical illness myopathy. Curr Opin Rheumatol 24: 616-622.
3. Matsumoto N, Nakamura T, Yasui Y, Torii J (2000) Analysis of muscle proteins in acute quadriplegic myopathy. Muscle Nerve 23: 1270-1276. (Pubitemid 30602250)
4. Larsson L, Li XP, Edstrom L, Eriksson LI, Zackrisson H, et al. (2000) Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels. Critical Care Medicine 28: 34-45. (Pubitemid 30091026)
5. Ahlbeck K, Fredriksson K, Rooyackers O, Maback G, Remahl S, et al. (2009) Signs of critical illness polyneuropathy and myopathy can be seen early in the ICU course. Acta Anaesthesiol Scand 53: 717-723.
6. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G (2009) Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev: 1: CD006832.
7. Latronico N, Bolton CF (2011) Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 10: 931-941.
8. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, et al. (2003) One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348: 683-693. (Pubitemid 36237037)
9. Wilcox ME, Herridge MS (2010) Long-term outcomes in patients surviving acute respiratory distress syndrome. Semin Respir Crit Care Med 31: 55-65.
10. Rudis MI, Guslits BJ, Peterson EL, Hathaway SJ, Angus E, et al. (1996) Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit. Crit Care Med 24: 1749-1756. (Pubitemid 26347392)
11. Seneff MG, Wagner D, Thompson D, Honeycutt C, Silver MR (2000) The impact of long-term acute-care facilities on the outcome and cost of care for patients undergoing prolonged mechanical ventilation. Crit Care Med 28: 342-350. (Pubitemid 30120870)
12. Friedrich O, Fink RH, Hund E (2005) Understanding critical illness myopathy: approaching the pathomechanism. J Nutr 135: 1813S-1817S. (Pubitemid 40980740)
13. Ochala J, Gustafson AM, Diez ML, Renaud G, Li M, et al. (2011) Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms. J Physiol 589: 2007-2026.
14. Llano-Diez M, Gustafson AM, Olsson C, Goransson H, Larsson L (2011) Muscle wasting and the temporal gene expression pattern in a novel rat intensive care unit model. BMC Genomics 12: 602.
15. Renaud G, Llano-Diez M, Ravar B, Gorza L, Feng HZ, et al. (2013) Sparing of muscle mass and function by passive loading in an experimental intensive care unit model. J Physiol 591(Pt 5):1385-1402.
16. Llano-Diez M, Renaud G, Andersson M, Marrero HG, Cacciani N, et al. (2012) Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading. Crit Care 16: R209.
17. Banduseela VC, Chen YW, Kultima HG, Norman HS, Aare S, et al. (2013) Impaired autophagy, chaperone expression, and protein synthesis in response to critical illness interventions in porcine skeletal muscle. Physiol Genomics 45: 477-486.
18. Banduseela VC, Ochala J, Chen YW, Goransson H, Norman H, et al. (2009) Gene expression and muscle fiber function in a porcine ICU model. Physiol Genomics 39: 141-159.
19. Aare S, Ochala J, Norman HS, Radell P, Eriksson LI, et al. (2011) Mechanisms underlying the sparing of masticatory versus limb muscle function in an experimental critical illness model. Physiol Genomics 43: 1334-1350.
20. Aare S, Radell P, Eriksson LI, Akkad H, Chen YW, et al. (2013) Effects of corticosteroids in the development of limb muscle weakness in a porcine intensive care unit model. Physiol Genomics 45: 312-320.
21. Aare S, Radell P, Eriksson LI, Chen YW, Hoffman EP, et al. (2012) Role of sepsis in the development of limb muscle weakness in a porcine intensive care unit model. Physiol Genomics 44: 865-877.
22. Nordquist J, Hoglund AS, Norman H, Tang X, Dworkin B, et al. (2007) Transcription factors in muscle atrophy caused by blocked neuromuscular transmission and muscle unloading in rats. Mol Med 13: 461-470. (Pubitemid 47585740)
23. Norman H, Nordquist J, Andersson P, Ansved T, Tang X, et al. (2006) Impact of post-synaptic block of neuromuscular transmission, muscle unloading and mechanical ventilation on skeletal muscle protein and mRNA expression. Pflugers Arch 453: 53-66. (Pubitemid 44454887)
24. Norman H, Zackrisson H, Hedstrom Y, Andersson P, Nordquist J, et al. (2009) Myofibrillar protein and gene expression in acute quadriplegic myopathy. J Neurol Sci 285: 28-38.
25. Dworkin BR, Dworkin S, Tang X (2000) Carotid and aortic baroreflexes of the rat: I. Open-loop steady-state properties and blood pressure variability. Am J Physiol Regul Integr Comp Physiol 279: R1910-1921.
26. Dworkin BR, Dworkin S (1990) Learning of physiological responses: I. Habituation, sensitization, and classical conditioning. Behav Neurosci 104: 298-319. (Pubitemid 20168868)
27. Larsson L, Grimby G, Karlsson J (1979) Muscle Strength and Speed of Movement in Relation to Age and Muscle Morphology. Journal of Applied Physiology 46: 451-456. (Pubitemid 9163080)
28. Franch HA, Price SR (2005) Molecular signaling pathways regulating muscle proteolysis during atrophy. Curr Opin Clin Nutr Metab Care 8: 271-275. (Pubitemid 40586185)
29. Mitch WE, Goldberg AL (1996) Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335: 1897-1905. (Pubitemid 26419198)
30. Kabeya Y, Mizushima N, Uero T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. Embo Journal 19: 5720-5728.
31. Schiaffino S, Mammucari C (2011) Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle 1: 4.
32. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, et al. (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell Biology 3: 1014-1019. (Pubitemid 34428747)
33. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, et al. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412. (Pubitemid 38534545)
34. Han B, Zhu MJ, Ma C, Du M (2007) Rat hindlimb unloading down-regulates insulin like growth factor-1 signaling and AMP-activated protein kinase, and leads to severe atrophy of the soleus muscle. Appl Physiol Nutr Metab 32: 1115-1123.
35. Nakao R, Hirasaka K, Goto J, Ishidoh K, Yamada C, et al. (2009) Ubiquitin Ligase Cbl-b Is a Negative Regulator for Insulin-Like Growth Factor 1 Signaling during Muscle Atrophy Caused by Unloading. Molecular and Cellular Biology 29: 4798-4811.
36. Dupont E, Cieniewski-Bernard C, Bastide B, Stevens L (2011) Electro-stimulation during hindlimb unloading modulates PI3K-AKT downstream targets without preventing soleus atrophy and restores slow phenotype through ERK. Am J Physiol Regul Integr Comp Physiol 300: R408-417.
37. Marimuthu K, Murton AJ, Greenhaff PL (2011) Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans. Journal of Applied Physiology 110: 555-560.
38. Glass DJ (2010) PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. Curr Top Microbiol Immunol 346: 267-278.
39. Baehr LM, Furlow JD, Bodine SC (2011) Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. J Physiol 589: 4759-4776.
40. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, et al. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708. (Pubitemid 33104839)
41. Martin AF (1981) Turnover of cardiac troponin subunits. Kinetic evidence for a precursor pool of troponin-I. J Biol Chem 256: 964-968.
42. Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, et al. (2009) During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 185: 1083-1095, 2009
43. Sandri M (2010) Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy. Am J Physiol Cell Physiol 298: C1291-1297.
44. Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, et al. (2009) Autophagy Is Required to Maintain Muscle Mass. Cell Metabolism 10: 507-515.
45. Yogev O, Shaulian E (2010) Jun proteins inhibit autophagy and induce cell death. Autophagy 6: 566-567.
46. Furuno K, Goodman MN, Goldberg AL (1990) Role of Different Proteolytic Systems in the Degradation of Muscle Proteins during Denervation Atrophy. Journal of Biological Chemistry 265: 8550-8557.
47. Cuervo AM, Bergamini E, Brunk UT, Droge W, Ffrench M, et al. (2005) Autophagy and aging - The importance of maintaining "clean" cells. Autophagy 1: 131-140.
48. Bonaldo P, Sandri M (2013) Cellular and molecular mechanisms of muscle atrophy. Disease Models & Mechanisms 6: 25-39.
49. Carmeli E, Moas M, Reznick AZ, Coleman R (2004) Matrix metalloproteinases and skeletal muscle: a brief review. Muscle Nerve 29: 191-197. (Pubitemid 38166839)
50. Giannelli G, De Marzo A, Marinosci F, Antonaci S (2005) Matrix metalloproteinase imbalance in muscle disuse atrophy. Histol Histopathol 20: 99-106. (Pubitemid 40028988)
51. Skittone LK, Liu X, Tseng A, Kim HT (2008) Matrix metalloproteinase-2 expression and promoter/enhancer activity in skeletal muscle atrophy. J Orthop Res 26: 357-363.
52. Ali MAM, Cho WJ, Hudson B, Kassiri Z, Granzier H, et al. (2010) Titin is a Target of Matrix Metalloproteinase-2 Implications in Myocardial Ischemia/ Reperfusion Injury. Circulation 122: 2039-2047.
53. Choi YC, Dalakas MC (2000) Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology 54: 65-71.
54. Liu YF, Steinacker JM (2001) Changes in skeletal muscle heat shock proteins: Pathological significance. Frontiers in Bioscience 6: D12-D25.
55. Parcellier A, Schmitt E, Brunet M, Hammann A, Solary E, et al. (2005) Small heat shock proteins HSP27 and alphaB-crystallin: cytoprotective and oncogenic functions. Antioxid Redox Signal 7: 404-413. (Pubitemid 40279808)
56. Beckmann RP, Mizzen LE, Welch WJ (1990) Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly. Science 248: 850-854.
57. Chen B, Piel WH, Gui LM, Bruford E, Monteiro A (2005) The HSP90 family of genes in the human genome: Insights into their divergence and evolution. Genomics 86: 627-637. (Pubitemid 41752943)
58. Cros N, Tkatchenko AV, Pisani DF, Leclerc L, Leger JJ, et al. (2001) Analysis of altered gene expression in rat soleus muscle atrophied by disuse. J Cell Biochem 83: 508-519. (Pubitemid 33027494)
59. Stevenson EJ, Giresi PG, Koncarevic A, Kandarian SC (2003) Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. J Physiol 551: 33-48. (Pubitemid 37062910)
60. Sakurai T, Fujita Y, Ohto E, Oguro A, Atomi Y (2005) The decrease of the cytoskeleton tubulin follows the decrease of the associating molecular chaperone alphaB-crystallin in unloaded soleus muscle atrophy without stretch. FASEB J 19: 1199-1201. (Pubitemid 40946464)
61. Carmeli E, Haimovitch TG, Nemcovsky CE (2006) Expression of matrix metalloproteinase 2 and heat shock protein-72 in immobilized muscle in rats. J Musculoskelet Neuronal Interact 6: 96-102. (Pubitemid 43732832)
62. Seo Y, Lee K, Park K, Bae K, Choi I (2006) A proteomic assessment of muscle contractile alterations during unloading and reloading. J Biochem 139: 71-80. (Pubitemid 43258848)
63. Arrigo AP, Simon S, Gibert B, Kretz-Remy C, Nivon M, et al. (2007) Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett 581: 3665-3674. (Pubitemid 47086314)
64. Ferrer-Martinez A, Montell E, Montori-Grau M, Garcia-Martinez C, Gomez-Foix AM, et al. (2006) Long-term cultured human myotubes decrease contractile gene expression and regulate apoptosis-related genes. Gene 384: 145-153. (Pubitemid 44767962)
65. Stephanou A, Isenberg DA, Akira S, Kishimoto T, Latchman DS (1998) The nuclear factor interleukin-6 (NF-IL6) and signal transducer and activator of transcription-3 (STAT-3) signalling pathways co-operate to mediate the activation of the hsp90beta gene by interleukin-6 but have opposite effects on its inducibility by heat shock. Biochem J 330 (Pt 1): 189-195.
66. Dalman FC, Scherrer LC, Taylor LP, Akil H, Pratt WB (1991) Localization of the 90-Kda Heat-Shock Protein-Binding Site within the Hormone-Binding Domain of the Glucocorticoid Receptor by Peptide Competition. Journal of Biological Chemistry 266: 3482-3490. (Pubitemid 21909240)